Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.867190
- By:
- Publication type:
- Article
Works by Brill, Livnat
Results: 16
1
2
Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple Sclerosis.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 11, p. 3989, doi. 10.1007/s10072-023-06909-3
- By:
- Publication type:
- Article
3
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 12, p. 1510, doi. 10.1001/jamaneurol.2021.3599
- By:
- Publication type:
- Article
4
Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7117, doi. 10.3390/ijms23137117
- By:
- Publication type:
- Article
5
Time limited immunomodulatory functions of transplanted neural precursor cells.
- Published in:
- Glia (0894-1491), 2013, v. 61, n. 2, p. 140, doi. 10.1002/glia.22420
- By:
- Publication type:
- Article
6
Brain MRI activity during the year before pregnancy can predict post-partum clinical relapses.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2232, doi. 10.1177/13524585211002719
- By:
- Publication type:
- Article
7
Increased anti-KIR4.1 antibodies in multiple sclerosis: Could it be a marker of disease relapse?
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 5, p. 572, doi. 10.1177/1352458514551779
- By:
- Publication type:
- Article
8
Anti‐ and pro‐inflammatory milieu differentially regulate differentiation and immune functions of oligodendrocyte progenitor cells.
- Published in:
- Immunology, 2024, v. 171, n. 4, p. 618, doi. 10.1111/imm.13757
- By:
- Publication type:
- Article
9
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS.
- Published in:
- Glia (0894-1491), 2023, v. 71, n. 12, p. 2815, doi. 10.1002/glia.24453
- By:
- Publication type:
- Article
11
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.
- Published in:
- Glia (0894-1491), 2022, v. 70, n. 6, p. 1191, doi. 10.1002/glia.24165
- By:
- Publication type:
- Article
12
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.
- Published in:
- Annals of Neurology, 2022, v. 91, n. 6, p. 796, doi. 10.1002/ana.26343
- By:
- Publication type:
- Article
13
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 12, p. 1453, doi. 10.1177/1352458510380416
- By:
- Publication type:
- Article
14
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.612304
- By:
- Publication type:
- Article
15
Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00835
- By:
- Publication type:
- Article
16
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
- Published in:
- 2016
- By:
- Publication type:
- journal article